PLoS ONE (Jan 2015)

Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.

  • Felipe Vaca-Paniagua,
  • Rosa María Alvarez-Gomez,
  • Hector Aquiles Maldonado-Martínez,
  • Carlos Pérez-Plasencia,
  • Veronica Fragoso-Ontiveros,
  • Federico Lasa-Gonsebatt,
  • Luis Alonso Herrera,
  • David Cantú,
  • Enrique Bargallo-Rocha,
  • Alejandro Mohar,
  • Geoffroy Durand,
  • Nathalie Forey,
  • Catherine Voegele,
  • Maxime Vallée,
  • Florence Le Calvez-Kelm,
  • James McKay,
  • Maude Ardin,
  • Stéphanie Villar,
  • Jiri Zavadil,
  • Magali Olivier

DOI
https://doi.org/10.1371/journal.pone.0126762
Journal volume & issue
Vol. 10, no. 5
p. e0126762

Abstract

Read online

Triple negative breast cancer (TNBC), defined by the lack of expression of the estrogen receptor, progesterone receptor and human epidermal receptor 2, is an aggressive form of breast cancer that is more prevalent in certain populations, in particular in low- and middle-income regions. The detailed molecular features of TNBC in these regions remain unexplored as samples are mostly accessible as formalin-fixed paraffin embedded (FFPE) archived tissues, a challenging material for advanced genomic and transcriptomic studies. Using dedicated reagents and analysis pipelines, we performed whole exome sequencing and miRNA and mRNA profiling of 12 FFPE tumor tissues collected from pathological archives in Mexico. Sequencing analyses of the tumor tissues and their blood pairs identified TP53 and RB1 genes as the most frequently mutated genes, with a somatic mutation load of 1.7 mutations/exome Mb on average. Transcriptional analyses revealed an overexpression of growth-promoting signals (EGFR, PDGFR, VEGF, PIK3CA, FOXM1), a repression of cell cycle control pathways (TP53, RB1), a deregulation of DNA-repair pathways, and alterations in epigenetic modifiers through miRNA:mRNA network de-regulation. The molecular programs identified were typical of those described in basal-like tumors in other populations. This work demonstrates the feasibility of using archived clinical samples for advanced integrated genomics analyses. It thus opens up opportunities for investigating molecular features of tumors from regions where only FFPE tissues are available, allowing retrospective studies on the search for treatment strategies or on the exploration of the geographic diversity of breast cancer.